Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience

Letter from the Editor

(2010) Ronald W. Ellis et al.   Human vaccines & immunotherapeutics

Global, regional, and national causes of child mortality in 2008: a systematic analysis

(2010) Robert E Black et al.   LANCET

Global use of Haemophilus influenzae type b conjugate vaccine

(2010) Linda R. Ojo et al.   VACCINE

Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience

(2010) R.A. Hajjeh et al.   VACCINE

Childhood Bacterial Meningitis in Ulaanbaatar, Mongolia, 2002–2004

(2009) Jamsran Mendsaikhan et al.   CLINICAL INFECTIOUS DISEASES

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

(2009) James P Watt et al.   LANCET

Economic evaluations ofHaemophilus influenzaetype b vaccine: systematic review of the literature

(2009) Ulla K Griffiths et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda

(2008) Rosamund Lewis   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability?

(2008) P. Lydon et al.   VACCINE

Progress in Vaccination against Haemophilus influenzae type b in the Americas

(2008) M. Carolina Danovaro-Holliday et al.   PLOS MEDICINE